Nephrogenic Diabetes Insipidus Treatments
Find Nephrogenic Diabetes Insipidus Treatments
Desmopressin Acetate
What is DDAVP (Desmopressin Acetate)?
Approved To Treat
Top Global Experts
Related Clinical Trials
Summary: Cardiopulmonary bypass (CPB) is a process that uses a pump that temporarily takes over the function of the heart and lungs during cardiac surgery to maintain blood circulation and oxygenation. Using CPB during cardiac surgery can result in complications with blood clotting. Blood clotting is achieved when molecules in the blood, called platelets, are able to form together with the help of other cl...
Background: Cushing syndrome (CS) is a set of diseases that develop when the body produces too much adrenocorticotropic hormone (ACTH). ACTH stimulates the production of a hormone called cortisol. Excess cortisol can cause serious issues, such as diabetes, high blood pressure, weight gain, and mood changes. Diagnosing CS early can be difficult. One test used to diagnose CS, the desmopressin (Desmo) stimulatio...
Summary: This randomized controlled trial will evaluate whether restricting bedtime digital-device use improves the response to desmopressin in children with primary monosymptomatic nocturnal enuresis. Participants will receive desmopressin for 8 weeks and will be assigned to either bedtime device restriction or usual screen habits.
Related Latest Advances
Brand Information
- 4 mcg/mL in single-dose ampule
- 40 mcg/10 mL (4 mcg/mL) in multiple-dose vial
- Moderate to severe renal impairment defined as a creatinine clearance below 50 mL/min
- Hyponatremia or a history of hyponatremia
- Known or suspected syndrome of inappropriate antidiuretic hormone (SIADH) secretion
- Polydipsia
- Concomitant use with loop diuretics
- Concomitant use with systemic or inhaled glucocorticoids
- During illnesses that can cause fluid or electrolyte imbalance, such as gastroenteritis, salt-wasting nephropathies, or systemic infection
- Heart failure
- Uncontrolled hypertension
- Hyponatremia
- Hypotension and Hypertension
- Increased risk of thrombosis in patients with von Willebrand's Disease Type IIB
- Hypersensitivity reactions
- Fluid retention


